MARKET

ICUI

ICUI

ICU Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

242.81
-2.34
-0.95%
After Hours: 242.81 0 0.00% 16:00 09/24 EDT
OPEN
244.12
PREV CLOSE
245.15
HIGH
244.56
LOW
241.69
VOLUME
88.99K
TURNOVER
--
52 WEEK HIGH
282.00
52 WEEK LOW
176.19
MARKET CAP
5.15B
P/E (TTM)
50.93
1D
5D
1M
3M
1Y
5Y
Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Today we will run through one way of estimating the intrinsic value of ICU Medical, Inc. ( NASDAQ:ICUI ) by projecting...
Simply Wall St. · 09/18 14:31
Director Of Icu Medical Trades $832.07 Thousand In Company Stock
Elisha W Finney, Director at Icu Medical (NASDAQ:ICUI), made a large buy and sell of company shares on September 14, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 14...
Benzinga · 09/15 14:40
Insider Sell: Icu Medical Inc/de
MT Newswires · 09/13 11:56
ICU Medical Pulls Amino Acid IV Products After Foreign Substances Found In Batch
ICU Medical Inc (NASDAQ: ICUI), a California-based infusion therapy company, is 
Benzinga · 09/09 18:46
Company News for Sep 9, 2021
Companies In The News Are: COIN, TSLA, SPB, ICUI
Zacks · 09/09 13:34
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.
Benzinga · 09/09 12:35
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
Benzinga · 09/09 12:17
Raymond James Adjusts ICU Medical's Price Target to $286 from $220, Keeps Outperform Rating
MT Newswires · 09/09 12:06
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICUI. Analyze the recent business situations of ICU Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICUI stock price target is 296.00 with a high estimate of 302.00 and a low estimate of 286.00.
EPS
Institutional Holdings
Institutions: 409
Institutional Holdings: 22.74M
% Owned: 107.22%
Shares Outstanding: 21.21M
TypeInstitutionsShares
Increased
89
1.16M
New
24
136.86K
Decreased
91
865.36K
Sold Out
34
205.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Chief Executive Officer/Director
Vivek Jain
Chief Financial Officer/Treasurer
Brian Bonnell
Chief Operating Officer
Christian Voigtlander
Vice President/General Counsel/Secretary
Virginia Sanzone
Vice President/General Manager
Daniel Woolson
Lead Director/Independent Director
David Greenberg
Director
George Lopez
Independent Director
Donald Abbey
Independent Director
Elisha Finney
Independent Director
Laurie Hernandez
Independent Director
David Hoffmeister
Independent Director
Robert Swinney
No Data
About ICUI
ICU Medical, Inc. (ICU) develops, manufactures and sells medical products used in infusion therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical safety. ICU's primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Cogent, which is a two-in-one hemodynamic monitoring system. CardioFlo, which is a hemodynamic monitoring system. TDQ and OptiQ, which are cardiac output monitoring catheters. TriOxTM, which is venous oximetry catheters. Transpac are blood pressure transducers. SafeSet, which is a closed blood sampling and conservation system.

Webull offers kinds of ICU Medical Inc stock information, including NASDAQ:ICUI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICUI stock methods without spending real money on the virtual paper trading platform.